Phenytoin Sodium Injection
Product Images NDC 0404-9932

5 FDA label images from Henry Schein, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Phenytoin Sodium (NDC 0404-9932). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Formula1.jpg (Formula1)
Chemical structure of Phenytoin Sodium showing its molecular formula C15H11N2NaO2 and molecular weight 274.25. The diagram illustrates the arrangement of atoms and bonds in the active ingredient molecule.*
FDA Label Image

Image1.jpg (Image1)

Image1.jpg (Image1)
A data table listing drugs that affect phenytoin serum concentrations. It categorizes drugs that may increase, decrease, or either increase or decrease phenytoin serum levels, along with examples for each category such as antiepileptic drugs, azoles, antineoplastic agents, and others. The table includes a footnote about St. John's wort.*
FDA Label Image

Image2.jpg (Image2)

Image2.jpg (Image2)
A data table titled 'Table 2: Drugs Affected by Phenytoin' listing various interacting agents and examples. The table categorizes drugs whose efficacy is impaired by phenytoin, including azoles, antineoplastic agents, delavirdine, neuromuscular blocking agents, warfarin, and other drugs such as corticosteroids and estrogens. It also lists drugs whose levels are decreased by phenytoin, including antiepileptic drugs, antilipidemic agents, antiviral agents, calcium channel blockers, and other medications.*
FDA Label Image

Image3.jpg (Image3)

FDA Label Image

Label1.jpg (Label1)

Label1.jpg (Label1)
Phenytoin Sodium 50 mg/mL injection, USP, single dose vial label. The label states 100 mg/2 mL concentration, for intravenous or intramuscular use, with storage instructions at controlled room temperature (68°F to 77°F). It includes manufacturer information for Henry Schein, Inc., lot and expiration placeholders, and usage warnings about solution clarity and administration rate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.